Biosidus zwiększa moce produkcyjne w zakresie leków biologicznych i wzmacnia globalne możliwości dostaw agalzydazy beta

agalzydase betaPositive

AI Analysis

Summary

Biosidus, an Argentine biotechnology company, announced the launch of a new facility equipped with bioreactors to increase manufacturing capacity for agalzydase beta and strengthen global supply capabilities for biologic drugs.

Importance:4/10

Sentiment:

0.60

manufacturingcapacity expansionbiosimilarsbioreactorglobal supply

Read the original article

Published by PR Newswire Biotech on August 27, 2026 11:10 AM

Read Original